Search results
Pfizer Reportedly Plans D2C COVID and Migraine Drug Platform
PYMNTS.com· 1 day agoPharmaceutical giant Pfizer is reportedly creating an online platform selling anti-COVID and...
Pfizer (PFE) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks via Yahoo Finance· 2 days agoWhile the top- and bottom-line numbers for Pfizer (PFE) give a sense of how the business performed...
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expectations Amidst Revenue Decline
GuruFocus.com via Yahoo Finance· 2 days agoFull-Year Guidance: Adjusted EPS guidance raised to $2.15 to $2.35, reaffirms revenue guidance of...
Pfizer profits drop on lower Covid-19 product sales
AFP via Yahoo Finance· 2 days agoPfizer reported a drop in profits on lower sales of Covid-19 related profits Wednesday as it steers investments to other pharmaceutical areas and...
Pfizer’s first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Market Watch· 2 days agoAn expected drop in COVID-19-related product sales, including antiviral Paxlovid and vaccine...
Pfizer Q1 earnings: non-Covid product sales help post revenues of $14.9 billion despite Comirnaty,...
Invezz· 2 days agoPfizer Inc. has announced its financial outcomes for the first quarter of 2024, displaying strong...
Pfizer plans to be 'very active' in obesity market, but CEO mum on precise R&D plans
FierceBiotech· 1 day agoPfizer’s 2024 revival tour is off and running, but the Big Pharma remains mum on one critical...
Pfizer Stock Gets Boost From Better-Than-Expected Earnings
Investopedia· 2 days agoPfizer (PFE) shares rose Wednesday after first-quarter earnings and revenue fell less than expected,...
Pfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dose - Triangle Business...
The Business Journals· 4 days agoThe U.S. Food and Drug Administration has approved a gene therapy developed by Pfizer and...
Pfizer Inc. (PFE): A New Perspective – Stocks Register
Stocks Register· 21 hours agoPfizer Inc. (NYSE:PFE) concluded the trading at $27.18 on Wednesday, May 01, with a rise of 6.09% from its closing price on previous day. Taking a look at stock we notice ...